Linda Huber
Analyst · Manav Patnaik with Barclays. Your line is open
Thanks, Baer, and hello to everyone on the call. MSCI's second quarter was another quarter of strong financial performance. On the operating side of our performance was solid but a tough lap given the exceptional second quarter in 2018. And double-digit organic subscription run rate growth was driven by strength across regions and major client segments. Specifically, the Americas were up 8%, EMEA was up 11% and Asia was up 13%. Asset owners, asset managers and broker-dealers, which collectively comprise more than 80% of our subscription run rate, saw organic subscription run rate growth of 9%, 10% and 10%, respectively. Our strong focus on continually adding value to our clients has helped us achieve a retention rate of 95.5% in Q2, the highest level in the last decade. Our consistently high retention rates have helped drive organic subscription run rate growth of approximately 10% for the last 7 consecutive quarters. For recurring net new sales, the first half was up 11% with Q2 down 3%. As I mentioned previously, the lower growth rate in the second quarter was the result of lapping a very strong Q2 2018. Also in Q2, we saw continued momentum across product segments. I'll now discuss specifics for each of the product lines. First for ESG. We continued our exceptional run across client segments and geographies. Within client segments, run rate growth was 24% for our larger segment, asset managers, which was complemented by exceptional growth of more than 50% for hedge funds and broker-dealers. Across geographies, we had run rate growth of 50% in Asia, 27% in EMEA and 18% in the Americas. It was also our second highest quarter ever in terms of both recurring sales and recurring net new sales for ESG. Second, Index delivered another quarter of double-digit subscription run rate growth with Factors growing at 25%, ESG growing at 48% and custom and specialized modules growing at 14%. And we continue to see consistent performance in our core market cap products, which had 10% growth. Additionally, we have strong retention rate of 97%. Third, for Analytics, as we repeatedly mentioned in previous calls, operating metrics can be lumpy quarter-over-quarter. This is increasingly so as we're seeing larger and more complex deals being closed. Our recurring sales for the quarter was $14 million, lower than second quarter of 2018, which was itself up 44% over Q2 '17 making for a tough comparison. However, recurring sales were up 7% compared to the first quarter of 2019. We continue to have positive momentum with a strong retention rate of 94% and continued strength in multi-asset class and fixed income Analytics, which collectively had run rate growth of 7%. And finally, for Real Estate, our organic run rate growth was 11% with strong traction in our market information offering. Finally, we'd like to spotlight our nonrecurring or onetime sale, which were up 7% to $9 million versus the prior year period primarily driven by increased sales in our index derivatives and RiskManager product offerings. Next, turning to our performance in ETF. We continued to benefit from our focus on derivatives with listed futures and options revenue growing 20% driven by 17% year-over-year volume growth. Most notably, volume and listed futures linked to MSCI's EM and ESA indices together grew 24%. ETF ABF revenue was down about 1% with a modest increase in year-over-year average AUM in equity ETFs linked into MSCI Indices offset by year-over-year decline in average basis points. Equity ETF assets under management linked to MSCI Indices ended the quarter at $819 billion, up 10% versus prior year driven by market appreciation across all geographies and continued flows into U.S. exposure products offset by outflows from emerging market exposures. Overall, we saw more than $7 billion of inflows into ETFs based on our Factor in ESG Indexes. Additionally, there's an inflow of $5.9 billion in funds based on U.S. exposure indexes where half of the flows were in ETFs based on our Factor indexes. These flows were directed primarily into low volatility products while more than 1/4 of the inflows into ETFs were based on our ESG Indexes. And turning now to capital allocation. We're continuing our commitment to returning capital to shareholders with a 17% increase in our quarterly dividend or an increase to $0.68 from $0.58 per share. We have consistently increased our dividends to shareholders, which has grown at a CAGR of 30% for the last 5 years. We had no share repurchases during the quarter, as it is our policy to repurchase opportunistically. As a reminder, however, we have returned more than $1 billion through share repurchases since the beginning of 2018. Looking at our cash balance. Our cash balance at the end of Q2 was $771 million. And that our policy is to maintain a minimum of approximately $200 million to $250 million of cash globally for general operating purposes. Turning to free cash flow for Q2. This was $177 million, down $23 million from Q2 2018. The primary drivers of this decline were the timing of collections, higher payments for interest payments and cash expenses particularly offset by benefits from lower tax payments. Our approach to capital allocation remains the same with no changes to our dividend policy, our leverage target or our approach to repurchases. And lastly, I'd like to provide an update on our guidance for the year. Given our strong business performance and our focus on driving growth, we will continue with our plan to invest on a number of high-returning growth opportunities. These investments are expected to drive our adjusted EBITDA expenses and CapEx to the high end of the guidance range or $685 million to $705 million for EBITDA expenses and $45 million to $55 million for CapEx. With regards to our tax guidance, we expect our full year effective tax rate to be between 8% and 11%. This includes the income tax benefit related to divesting of certain multiyear PSUs in the first quarter of approximately 11 percentage points, which has been excluded from adjusted EPS. Excluding this benefit, we expect the effective tax rate used for our adjusted EPS to be in the range of 19% to 22%. And with that, we'll open the line to take your questions.